|Achieving Regulatory Compliance When Moving to ICP-MS for Elemental Impurity Analysis|
|Event Date: November 06, 2013 at 11:00 AM EST|
As the pharmaceutical industry prepares for changes to compendial and regulatory standards for elemental impurity analysis, QA/QC and laboratory scientists are tasked with adapting their operations to include data management, analysis, and reporting based on inductively coupled plasma–mass spectrometry (ICP–MS). Understanding the necessary technical controls to implement and manage analytical operations is crucial to ensure regulatory compliance. This 60-minute webcast will provide insight from leading industry experts on best practices and strategies to optimize the analytical workflow, data management, and data reporting when using ICP-MS.
Key Learning Objectives:
• Understand best practices in using ICP-MS to analyze elemental impurities
• Understand how to meet USP and ICH requirements for elemental impurity analysis
Patricia Van Arnum
Linda Doherty, PhD
Senior Product Manager
Software and Informatics Division
Mark Alasandro, PhD
Director of Pharmaceutical Analysis and Microbiology
IMPORTANT - PLEASE READ
This is a FREE streaming audio Webcast and does not require a phone line. If you have any questions regarding this Webcast, please contact Jamie Carpenter, firstname.lastname@example.org.
Register for this FREE Webcast!